Trials / Completed
CompletedNCT02503254
Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.
A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.0 (CHTP 1.0) Compared to Continuing to Use Conventional Cigarettes During 5 Days in Confinement.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Philip Morris Products S.A. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The overall goal of the study is to demonstrate the reduction of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) in adult smokers switching for 5 days from conventional cigarette (CC) to Carbon Heated Tobacco Product 1.0 (CHTP 1.0) as compared to smokers continuing to use CC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CHTP 1.0 | CHTP 1.0 ad libitum for 5 days in confinement |
| OTHER | Conventional Cigarette (CC) | Subject's own preferred brand of CC ad libitum for 5 days in confinement |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-09-01
- Completion
- 2016-03-01
- First posted
- 2015-07-20
- Last updated
- 2023-01-30
- Results posted
- 2017-03-10
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02503254. Inclusion in this directory is not an endorsement.